Join
Live feed
·
SECFilingvia Quantisnow
Taysha Gene Therapies Inc. logo

Taysha Gene Therapies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
TSHA· Taysha Gene Therapies Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TSHA (Taysha Gene Therapies Inc.) and more on Quantisnow.

Taysha Gene Therapies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits | Quantisnow